drugset / Trial / NCT00151294

The Efficacy and Safety of Escitalopram for Depression in Multiple Sclerosis

NCT00151294

RandomizedParallel-groupDouble-blindTreatment

Summary

Emotionally labile, depressed participants with multiple sclerosis treated with escitalopram will have a greater reduction in emotional lability scores and in their psychological distress scores than those who are randomized to receive placebo.

Timeline

Start
2004-11
Primary completion
Completion
2006-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Escitalopram Small molecule 10 mg